Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen W Reese

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Urology|September 17, 2013
A tissue graft model of DNA damage response in the normal and malignant human prostateTaija M Af Hällström, Hongjuan Zhao, Junqiang Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizerJunqiang Tian, Hongjuan Zhao, Rosalie Nolley, et al.
Lung|February 22, 2021
Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapyStephen W Reese, Eugene Cone, Maya Marchese, et al.
European Urology|February 5, 2014
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United StatesJeffrey J Leow, Stephen W Reese, Wei Jiang, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Urology|October 7, 2019
Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical CystectomyKarl H Tully, Marieke J Krimphove, Stephen W Reese, et al.
Plos One|November 1, 2022
Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapyEugene B Cone, Lorine Haeuser, Stephen W Reese, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
Clinical Genitourinary Cancer|December 14, 2022
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage AnalysisKarl H Tully, Sebastian Berg, Marco Paciotti, et al.
Urology Practice|March 14, 2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk CasesMark T Dawidek, Lina Posada Calderon, Juan Sebastian Arroyave Villada, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Urology|September 17, 2013
A tissue graft model of DNA damage response in the normal and malignant human prostateTaija M Af Hällström, Hongjuan Zhao, Junqiang Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizerJunqiang Tian, Hongjuan Zhao, Rosalie Nolley, et al.
Lung|February 22, 2021
Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapyStephen W Reese, Eugene Cone, Maya Marchese, et al.
European Urology|February 5, 2014
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United StatesJeffrey J Leow, Stephen W Reese, Wei Jiang, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Urology|October 7, 2019
Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical CystectomyKarl H Tully, Marieke J Krimphove, Stephen W Reese, et al.
Plos One|November 1, 2022
Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapyEugene B Cone, Lorine Haeuser, Stephen W Reese, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
Clinical Genitourinary Cancer|December 14, 2022
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage AnalysisKarl H Tully, Sebastian Berg, Marco Paciotti, et al.
Urology Practice|March 14, 2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk CasesMark T Dawidek, Lina Posada Calderon, Juan Sebastian Arroyave Villada, et al.
Pageof 3